GLP-1 drugs may increase NAION risk, but the absolute chance is low

GLP 1 Blindness Risk | Should You Be Worried? · 9:12 · Video: Doctor Eye Health · Watch at the source

In short: GLP-1 medications like Ozempic are linked to a rare eye condition called NAION, which can cause sudden vision loss. But with millions of users, the actual risk remains very low. Understanding the science and legal debates is key to making informed decisions about your health.

GLP-1 medications, such as Ozempic and Wegovy, are increasingly used for type 2 diabetes and weight loss. While they offer significant metabolic and cardiovascular benefits, researchers are investigating potential side effects, including rare vision complications like non-arteritic anterior ischemic optic neuropathy (NAION). A rare optic nerve stroke, known as NAION, may result in abrupt vision loss, and there is emerging evidence connecting GLP-1 drugs to this condition.

The risk of NAION associated with GLP-1 drugs appears to be higher in diabetic patients, particularly those taking semaglutide, the active ingredient in Ozempic. A study published in JAMA Ophthalmology found elevated rates of NAION among diabetic patients on semaglutide. However, the absolute risk remains low, with estimates suggesting that the chance of developing NAION while on GLP-1 drugs is minimal. This is important because millions of people are using these medications, and the overall incidence of NAION is rare.

Legal cases, such as the Engel family's lawsuit against Novo Nordisk, highlight the ongoing debate over whether GLP-1 drugs cause NAION. While observational data shows a correlation between GLP-1 use and NAION, causation is not yet proven. The legal question hinges on whether the drugs caused the harm, and scientific evidence is still being evaluated. Medical groups have raised concerns about the methodology of some studies, emphasizing the need for more detailed investigation to determine causation.

Opens the Intellect+ feed with this card first. Swipe up for the next one.

Sources

To cite this card, link to https://intellectplus.co.uk/app/health-glp-1-blindness-risk-should-you-be-worried.

How we source, check and correct cards: Editorial standards.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

Finding something worth knowing…